THE PRESSURE IS ON – LIVE WEBCAST Diagnosing and Improving Outcomes in CKD REGISTER TODAY

EARLY INTERVENTION CAN MAKE A DIFFERENCE

By identifying patients and intervening early, you can help slow the progression of kidney failure, reduce the risk of cardiovascular disease, and help your patients live a longer, dialysis-free life.2,4,5

EARLY INTERVENTION CAN SLOW DISEASE PROGRESSION IN CKD PATIENTS

Configure Image Component
CKD progression with and without early intervention
CKD progression with and without early intervention

Adapted from Alabama Public Department of Health, 2007 and Brenner BM et al, 2001.

ERA endorsement is for the promotion of education in general, therefore the specific content of this material is the responsibility of AstraZeneca.

Declared by Primary Care Diabetes Europe (PCDE) in the scientific or social interest of primary care practitioners.

Configure Image Component
Age standardized rate of hospitalization
Age standardized rate of hospitalization
Configure Image Component
Age standardized rate of HF and CV events
Age standardized rate of HF and CV events
Configure Image Component
Age standardized rate of death from any cause
Age standardized rate of death from any cause

Adapted from Go AS et al, 2004.

LEARN THE IMPORTANCE OF DIAGNOSING CKD EARLY FROM LEADING EXPERTS

WATCH THE PRESSURE IS ON WEBCAST VIDEO

The Pressure Is On – LIVE WEBCAST

Diagnosing and Improving Outcomes in CKD

CKD can be life-threatening condition that is vastly underdiagnosed. This webcast will provide medical education on disease state awareness to support the diagnosis of CKD and improve patient outcomes. Join leading experts to learn about the importance of diagnosing CKD early.

CKD, chronic kidney disease; CV, cardiovascular; eGFR, estimated glomerular filtration rate; GFR, glomerular filtration rate.

References

  1. Ryan TP et al. Am J Med. 2007;120(11):981–986.
  2. Ravera M et al. Am J Kidney Dis. 2011;57(1):71–77.
  3. GBD Chronic Kidney Disease Collaboration, Lancet. 2020;395(10225):709–733.
  4. Alabama Department of Public Health. Special Task Force on Chronic Kidney Disease report. April 2007. Accessed 20 November 2020.
    https://kipdf.com/special-task-force-on-chronic-kidney-disease-report-april-2007_5ad9b5767f8b9a9b248b45be.html
  5. Kidney Disease: The Basics. National Kidney Foundation. Published 5 April 2021. Accessed 4 February 2022.
    https://www.kidney.org/sites/default/files/web_kidneybasics_v4.pdf
  6. Brenner BM et al. N Engl J Med. 2001;345(12):861–869.
  7. Go AS et al. N Engl J Med. 2004;351(13):1296–1305.
  8. Levin A et al. Kidney Int. 2014;85(1):49–61.
  9. Estimated glomerular filtration rate (eGFR). National Kidney Foundation. Reviewed 14 September 2020. Accessed 25 November 2020.
    https://www.kidney.org/atoz/content/gfr
  10. Ghaderian SB et al. J Renal Inj Prev. 2014;3(4):109–110.
  11. Couser WG et al. Kidney Int. 2011;80(12):1258–1270.
  12. Measurement and estimation of kidney function. Abdominal Key. Accessed 2 November 2021.
    https://abdominalkey.com/measurement-and-estimation-of-kidney-function/
  13. Alyshah AS et al. REVEAL-CKD: Prevalence of and Patient Characteristics Associated With Undiagnosed Stage 3 Chronic Kidney Disease. Poster number: PO2337. Presented at: the American Diabetes Association 81st Scientific Sessions, 25–29 June 2021 (virtual).
  14. Kidney Disease Stats. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. December 2016. Accessed 25 November 2020.
    https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease
  15. Yacoub R, Habib H, Lahdo A, et al. Association between smoking and chronic kidney disease: A case control study. BMC Public Health. 2010;10:731.
  16. Schnaper HW. Pediatr Nephrol. 2014;29(2):193–202.

Modal Window Component Section Begins
Modal Window Component Section Ends